Biotech & Life Sciences

Atoll Financial Group offers financial and advisory services to lower-market and lower middle-market private entities in the Biotech and Life Sciences sector. While able to advise across many stages of a business’ life cycle, we specialize in positioning companies to raise Seed, Series A and Series B funding rounds with institutional investors globally. The skills needed to drive technological innovation differ from those necessary to finance and structure that innovation, in ways that it can be realized as a viable business. We envision our role as bridging these two domains. Our team balances expertise in both finance and science, enabling us to analyze primary data and conduct impartial literature reviews as proficiently as we manage financial structures and navigate regulatory compliance. Our enduring relationships with institutional investors, combined with this holistic approach, have secured over $1.3 billion in sell-side and ~$2 billion in buy-side mandates throughout our 15+ years of operation. We fervently believe in the life sciences' potential to benefit humanity and are committed to playing our part supporting founders and institutions that catalyze its impact.

 

Pursuant to the skill set of Atoll’s Biotech and Life Sciences Team which is comprised of PhDs in Biochemistry and Molecular Biology, Drug Discovery, Pharmaceutical Science, Pharmacology, Toxicology, Molecular Biophysics, Cellular Biophysics and Biological Sciences, we target businesses across a broad spectrum of sub-verticals, including, but not limited to, the domains of Oncology, Biochemistry, Neurosciences, Drug Discovery, Drug Delivery, Medical Devices, MedTech, AI Life Sciences tools, and all areas of the life sciences and their adjacencies, from biotechnology and healthcare to agriculture and industrial processes.  

 

Our primary focus lies in identifying promising technologies we can help turn into promising investment opportunities in privately held companies embarking on Seed and Series "A" funding rounds and providing advisory services in the capacity of Venture Partners or financial advisors, involving devising strategies and positioning companies to go to market, constructing a compelling investment thesis, skillfully sourcing qualified investors and negotiating investment terms.

 

Our strength comes from a profound understanding of the scientific aspects underlying our client's discoveries and cultivating a close and innovative relationship to craft a sophisticated Go-to-Market strategy. Our extensive connections with a broad spectrum of global institutional investors and deep understanding of financial market activities and trends, allow us to navigate the funding landscape effectively and provide invaluable insights throughout a company's growth and development.